In a 13G filing on Cardiome Pharma (Nasdaq: CRME), Steven Cohen's SAC Capital disclosed a 6.8% stake (4,327,480 shares) in ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE